TMEM88 is hypermethylated in NSCLC, which was verified in an expanded cohort that promoter CpG-island methylation was markedly higher in tumors than in matched non-malignant lung tissue [104]. This evidence concerns the gene TMEM88 and non-small cell lung carcinoma.